NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia

OBJECTIVE: The aim of the study was to investigate whether nucleophosmin type A mutation (NPM1A) in plasma was associated with the prognosis of patients with acute myeloid leukemia (AML). METHODS: Plasma NPM1A levels were investigated in 80 AML patients, 22 patients with benign hematopathy and 12 he...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chengming, Gao, Yujie, Yang, Liping, Shao, Huiyuan, li, Jie, Gao, Xuejun, Ma, Li, Lin, Mingming, Sui, Jingrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2018
Materias:
Topical Issue on Precision Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874735/
https://www.ncbi.nlm.nih.gov/pubmed/33817088
http://dx.doi.org/10.1515/biol-2018-0028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874735/
https://www.ncbi.nlm.nih.gov/pubmed/33817088
http://dx.doi.org/10.1515/biol-2018-0028

Ejemplares similares